• Product NameZomepirac Sodium
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityZomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.
• Target NamePDE inhibitor
• CAS No. 64092-48-4
• Calculated MW 313.71
• Formulation C15H13ClNNaO3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:[Na+].CN1C(CC([O-])=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1
  Pathways:Metabolism
  Receptor:PDE2
  Boling pt:470.8C
  Melting pt:
  Solubility:Water: 0.026 mg/mL
  Appearance:Faint Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Hata AN, et al. Mol Pharmacol. 2005 Mar;67(3):640-7.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting